Measurement of the glycaemic index (GI) of an enteral nutrition formulation in healthy subjects
Not Applicable
- Conditions
- one (healthy subjects)
- Registration Number
- DRKS00006739
- Lead Sponsor
- Fresenius Kabi Deutschland GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Healthy subjects who give informed consent to participate in the study
Exclusion Criteria
Aged < 18 or > 60 years/
Pregnant or lactating/
Body mass index (BMI) = 30kg/m2/
History of diabetes mellitus or fasting blood glucose value > 6.1 mmol/l/
Any known food allergy or intolerance/
Medical condition(s) or medication(s) known to affect glucose regulation or appetite and/or influence digestion and absorption of nutrients/
Use steroids, protease inhibitors, amphetamines or antipsychotics/
Use of medications known to affect glucose tolerance (excluding oral contraceptives)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determination of glycaemic index by comparing the blood sugar level enhancement after intake of the test product or a glucose solution within 2 hours after intake. Blood sugar measurement is done -5 and 0 minutes before and 15, 30, 45, 60, 90 and 120 minutes after intake. The blood sugar level measurement is done spectrophotometrically.
- Secondary Outcome Measures
Name Time Method